Friday, March 4, 2022

Roche lets go of etro, dumping phase 3 Crohn's prospect 18 months after posting weak colitis data

Roche tossed out Spark Therapeutics' choroideremia gene therapy SPK-7001, also known as RG6367, as well as nonalcoholic steatohepatitis (NASH) ...

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...